Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women

JAMA

Volumn 287, Issue 20, 2002, Pages 2668-2676

  Lindsay, Robert ^a   Gallagher, Christopher ^b   Kleerekoper, Michael ^c   Pickar, James H ^d  

^a HELEN HAYES HOSPITAL   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CARBONATE; COLLAGEN TYPE 1; COLLAGEN TYPE 1 AMINO TERMINAL PEPTIDE; CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE; OSTEOCALCIN; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HIP; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPINE; TREATMENT OUTCOME;

EID: 0037157169     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.20.2668     Document Type: Article

References (24)

1. Personal perspective on low-dosage estrogen therapy for postmenopausal women
2. Is low-dose hormone replacement therapy for postmenopausal women efficacious and desirable?
3. Patient-identified needs for hormone replacement therapy counseling: A qualitative study
4. Low-dose esterified estrogen therapy: Effects on bone, plasma estradiol concentrations, endometrium, and lipid levels
5. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART Study): A randomized controlled trial
6. The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women: A randomized, controlled trial
7. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women
8. Prevention of spinal osteoporosis in oophorectomised women
9. HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women: A 5-year randomized trial
10. Treatment of postmenopausal osteoporosis with transdermal estrogen
11. The minimum effective dose of estrogen for prevention of postmenopausal bone loss
12. Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy
13. Effect of progestin therapy on cortical and trabecular bone: Comparison with estrogen
14. Effects of hormone therapy on bone mineral density: Results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
15. Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late postmenopausal women
16. Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: A 2-year prospective study
17. The worldwide problem of osteoporosis: Insights afforded by epidemiology
18. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate
19. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism
20. Effects of 2 years of hormone replacement upon bone mass, serum lipids and lipoproteins
21. Continuous low-dose oestrogen and progestogen hormone replacement therapy: A randomised trial
22. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women
23. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding
24. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate